| Online: | |
| Visits: | |
| Stories: |
| Story Views | |
| Now: | |
| Last Hour: | |
| Last 24 Hours: | |
| Total: | |
Anti-HER2/neu Peptide-Conjugated Iron Oxide Nanoparticles for Targeted Delivery of Paclitaxel to Breast Cancer Cells
Tuesday, October 6, 2015 2:11
% of readers think this story is Fact. Add your two cents.
Where size matters
Nanoscale, 2015, Accepted Manuscript
DOI: 10.1039/C5NR04867B, Communication
DOI: 10.1039/C5NR04867B, Communication
Qingxin Mu, Forrest Kievit, Rajeev Kant, Guanyou Lin, Mike Jeon, Miqin Zhang
Nanoparticles (NPs) for targeted therapy are required to have appropriate size, stability, drug loading and release profiles, and efficient targeting ligands. However, many of existing NPs such as albumin, liposomes,…
The content of this RSS Feed (c) The Royal Society of Chemistry
Nanoparticles (NPs) for targeted therapy are required to have appropriate size, stability, drug loading and release profiles, and efficient targeting ligands. However, many of existing NPs such as albumin, liposomes,…
The content of this RSS Feed (c) The Royal Society of Chemistry
Source: http://nanochemistry.blogspot.com/2015/10/anti-her2neu-peptide-conjugated-iron.html
